# Cell Therapy for Diabetic Foot Ulcer

> **NCT05234086** · PHASE2 · UNKNOWN · sponsor: **Instituto para el Desarrollo Biotecnológico y la Innovación S.A.** · enrollment: 60 (estimated)

## Conditions studied

- Diabetic Foot Ulcer Associated With Type II Diabetes Mellitus
- Wound Heal

## Interventions

- **COMBINATION_PRODUCT:** InbioDerm + C plus advanced healing
- **PROCEDURE:** Advanced healing

## Key facts

- **NCT ID:** NCT05234086
- **Lead sponsor:** Instituto para el Desarrollo Biotecnológico y la Innovación S.A.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-02
- **Primary completion:** 2022-05
- **Final completion:** 2022-09-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-02-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05234086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05234086, "Cell Therapy for Diabetic Foot Ulcer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05234086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*